Fremanezumab, an anti-CGRP monoclonal antibody, reduces stimulated CGRP release from rat cranial dura mater

Vogler B, Nakajima J, Mackenzie K, Stratton J, Meßlinger K (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Cephalalgia Sage Publications

Publisher: SAGE PUBLICATIONS LTD

City/Town: LONDON

Pages Range: 360-361

Conference Proceedings Title: CEPHALALGIA

Event location: Dublin

Authors with CRIS profile

Birgit Vogler Lehrstuhl für Physiologie Julika Sertel-Nakajima Lehrstuhl für Physiologie Karl Meßlinger Professur für Zelluläre und Molekulare Neurophysiologie (Heisenberg-Professur)

How to cite

APA:

Vogler, B., Nakajima, J., Mackenzie, K., Stratton, J., & Meßlinger, K. (2019). Fremanezumab, an anti-CGRP monoclonal antibody, reduces stimulated CGRP release from rat cranial dura mater. In CEPHALALGIA (pp. 360-361). Dublin, IE: LONDON: SAGE PUBLICATIONS LTD.

MLA:

Vogler, Birgit, et al. "Fremanezumab, an anti-CGRP monoclonal antibody, reduces stimulated CGRP release from rat cranial dura mater." Proceedings of the 19th International Headache Congress of International-Headache-Society, Dublin LONDON: SAGE PUBLICATIONS LTD, 2019. 360-361.

BibTeX: Download